Molina Healthcare (NYSE:MOH) had its target price increased by equities research analysts at Morgan Stanley from $178.00 to $184.00 in a note issued to investors on Friday, BenzingaRatingsTable reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 27.01% from the stock’s previous close.
Several other analysts have also recently issued reports on the company. Barclays set a $145.00 target price on Sanderson Farms and gave the company a “hold” rating in a research report on Friday, May 31st. BMO Capital Markets set a C$106.00 price objective on FirstService and gave the stock a “market perform” rating in a research report on Monday, June 3rd. Bank of America cut Genesee & Wyoming from a “neutral” rating to an “underperform” rating and set a $88.65 price objective for the company. in a research report on Tuesday, April 30th. Finally, Wells Fargo & Co set a $12.00 price objective on Infosys and gave the stock a “hold” rating in a research report on Friday, May 31st. One investment analyst has rated the stock with a sell rating, six have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $160.25.
Shares of NYSE MOH opened at $144.87 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.57 and a quick ratio of 1.57. The company has a market cap of $8.98 billion, a PE ratio of 13.07, a PEG ratio of 0.99 and a beta of 1.28. The firm’s fifty day moving average is $144.00. Molina Healthcare has a 12-month low of $101.87 and a 12-month high of $159.00.
In other news, Director Daniel Cooperman sold 4,004 shares of the firm’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $155.00, for a total value of $620,620.00. Following the completion of the sale, the director now owns 4,096 shares of the company’s stock, valued at approximately $634,880. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Garrey Carruthers sold 1,300 shares of the firm’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $152.75, for a total value of $198,575.00. The disclosure for this sale can be found here. Insiders sold a total of 6,304 shares of company stock valued at $945,495 in the last three months. Insiders own 0.77% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the business. Parallel Advisors LLC lifted its position in Molina Healthcare by 97.9% during the 1st quarter. Parallel Advisors LLC now owns 186 shares of the company’s stock worth $26,000 after acquiring an additional 92 shares during the period. Cornerstone Advisors Inc. lifted its position in Molina Healthcare by 3,577.8% during the 1st quarter. Cornerstone Advisors Inc. now owns 331 shares of the company’s stock worth $47,000 after acquiring an additional 322 shares during the period. FTB Advisors Inc. lifted its position in Molina Healthcare by 367.6% during the 1st quarter. FTB Advisors Inc. now owns 346 shares of the company’s stock worth $48,000 after acquiring an additional 272 shares during the period. Financial Gravity Wealth Inc. acquired a new stake in Molina Healthcare during the 1st quarter worth about $54,000. Finally, Quadrant Capital Group LLC lifted its position in Molina Healthcare by 289.3% during the 1st quarter. Quadrant Capital Group LLC now owns 545 shares of the company’s stock worth $71,000 after acquiring an additional 405 shares during the period.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
See Also: Percentage Gainers
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.